Wu YY

No ORCID on file · 6 papers in corpus · active 2012-2023

Study types

  • review 1

Condition tags

  • adenomyosis 1
review 2023
Pulmonary embolism after diagnostic curettage in patient with adenomyosis and hysteromyoma: A case report and brief review of literature
Medicine ·doi:10.1097/md.0000000000036279

RATIONALE: Pulmonary embolism (PE) is a common cause of cardiovascular death whose major acquired risk factors include postoperative states, pregnancy, malignancy, and age. We report a case of PE that occurred after diagnostic curettage for…

2022
A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatment.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00999-y

BackgroundPatients with recurrent implantation failure (RIF) may have more uterine contractions. Several observational studies suggested that atosiban administration around embryo transfer resulted in higher pregnancy rates in RIF patients.…

2022
Predicting the probability of a live birth after a freeze-all based in vitro fertilization-embryo transfer (IVF-ET) treatment strategy.
Translational pediatrics ·doi:10.21037/tp-21-589

BackgroundThe predictors for live birth rate (LBR) following one episode of in vitro fertilization (IVF) cycle for patients using a "freeze-all" strategy are not entirely clear.MethodsA retrospective cohort study utilizing a prediction mode…

2018
Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors.
Journal of ovarian research ·doi:10.1186/s13048-018-0382-3

BackgroundCancer is widely believed to result from chronic inflammation, and red cell distribution width (RDW) and mean platelet volume (MPV) are considered as inflammatory markers for cancer. We investigated the values of RDW, MPV, and can…

2016
Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.
Oncotarget ·doi:10.18632/oncotarget.7497

Ovarian clear cell carcinoma (OCCC) is an aggressive neoplasm with a high recurrence rate that frequently develops resistance to platinum-based chemotherapy. There are few prognostic biomarkers or targeted therapies exist for patients with …

2012
Promoter methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma.
Molecular cancer ·doi:10.1186/1476-4598-11-53

BackgroundThis study is to analyze promoter methylation of various tumor suppressor genes in different types of ovarian carcinoma and to identify potential therapeutic targets of ovarian clear cell adenocarcinoma (OCCA).Materials and method…